Lymphedema is a chronic condition resulting from congenital defects or secondary damage due to surgical disruption, radiation, or trauma to the lymphatic system. It is estimated that 1 million Canadians1 suffer from lymphedema and it can affect men, women and children.2 3M has developed a system to help improve lives by effectively reducing edema, allowing mobility and reducing pain.3,4,5
The 3M™ Coban™ 2 Layer Compression Systems combines a layer of soft polyurethane foam with a cohesive compression bandage.
After application the two layers cohere to each other and reduce slippage during wear.6,7 This compression system is intended for single use only and may be worn up to seven days.6
3M™ Coban™ 2 Layer Compression Systems are indicated for therapeutic compression in the treatment of conditions such as venous leg ulcers and lymphedema.
3M™ Coban™ 2 Layer Compression Systems are so thin and flexible; you can wear normal shoes and clothes and return to your regular activities.
Compression is the cornerstone of treatment and is best used with exercise. This brochure is intended to provide examples of different exercises that patients can use. Refer to disclaimer in the brochure for more information.
3M™ Coban™ 2 Layer Compression System is designed for comfort, mobility and daily living. This patient brochure contains general information on compression, tips and product information.
1. Keast, D.H., Moffatt, C., Janmohammad, A. (2019, April). Lymphedema Impact and Prevalence International Study: The Canadian Data. Lymphat Res Biol., 17(2), 178–186. doi:10.1089/lrb.2019.0014.
2. Canadian Lymphedema Framework. What Is It? Available at https://canadalymph.ca/what-is-it/ .
3. Lamprou, D-A.A., Damstra, R.J., Partsch, H. (2011, May). Prospective, Randomized, Controlled Trial Comparing a New Two-Component Compression System with Inelastic Multicomponent Compression Bandages in the Treatment of Leg Lymphedema. American Society of Dermatologic Surgery, Inc., 37, 985-91. doi: 0.1111/j.1524-4725.2011.02002.x.
4. Moffatt, C., et al. (2012, March). A preliminary randomized controlled study to determine the application frequency of a new lymphoedema bandaging system, British Journal of Dermatology, 166(3), 624-632. doi: 10.1111/j.1365-2133.2011.10731.x.
5. Franks, P.J., Moffat, C.J., Murray, S., Reddick, M., Tiley, A., Schreiber, A. (2013, April). Evaluation of the performance of a new compression system in patients with lymphoedema. Int Wound J., 10(2),203-209. doi: 10.1111/j.1742-481X.2012.00958.x.
6. Moffatt, C., et al. (2008, June). A randomised controlled 8-week crossover clinical evaluation of the 3M Coban 2 Layer Compression System versus Profore to evaluate the product performance in patients with venous leg ulcers. Int Wound J., 5(2), 267-279. doi: 10.1111/j.1742-481X.2008.00487.x.
7. Mosti, G., Crespi, A., Mattaliano, V. (2011). Comparison Between a New, Two-component Compression System With Zinc Paste Bandages for Leg Ulcer Healing: A Prospective, Multicenter, Randomized, Controlled Trial Monitoring Subbandage Pressures. Wounds, 23(5), 126–134.